Plain-English translation of NCT06605872 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This trial is testing whether GlucoTab — a smartphone app designed to help manage blood sugar levels — works well in real hospital settings across Europe. The app helps doctors and nurses decide the right insulin doses for patients with type 2 diabetes who are staying in the hospital. Researchers want to see if using this app makes blood sugar management easier and safer compared to how it was done before.
Managing blood sugar levels in hospitalized patients is challenging and can affect how quickly they recover. This study aims to show whether this treatment helps hospitals provide better, safer, and more consistent insulin management across different countries.
You likely qualify if…
You likely don't qualify if…
If you join the study group, you would use the GlucoTab app during your hospital stay to help manage your insulin doses. Your hospital care team would use the app to guide their decisions about your insulin treatment. The study also compares your outcomes to a group of patients from the past year who received standard care without the app, so you would not need to do anything extra beyond your normal hospital care.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
Spain
Sponsor
Medical University of Graz
Enrollment target
~500 participants
Started
April 2025
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lichtenegger
Medical University of Graz
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.